Loading ...
introducing this as a vaccineprovokeda strong antibody reaction leading to immunity
Natural Acquired immunity Antigen A substancecausesthe formation of antibodies Humoral Antibody - mediated immunity
Foreign substancecausesus to Generate Antibodies Adaptive Immunity
a capacityto contributeto humoral immunity via antibody responses
this materialwill causean immune response to form antibodies
passive transfusion of HLA or human neutrophil antigen ( HNA ) and corresponding antibodies from the donor directed against antigens of the recipient(passive) is caused byAntibody - mediated TRALI
In such people glutencausesimmune reactions releasing antibodies
to prevent this from occurring in hopes of generating an immune response to decimate the tumor(passive) is designedImmune checkpoint blockade via antibodies
the tumour(passive) caused byantibody production and cell - mediated immunity
MHC - II presentationleadingto strong antibody - mediated immunity
by HLA class I(passive) caused byAntibody - mediated TRALI
vaccinesdesignedto generate protective antibody - mediated immunity
vaccinesdesignedto generate a protective antibody - mediated immunity
Antigensdiscoveredusing IgG antibody immunity
an immune responsewill causeimmunity via long - lasting antibodies
Transfer factors ... immune moleculescauseantigen - specific cell - mediated immunity
fentanyl , and an apolipoproteincausesvasodilatation , antibody - directed cell - mediated immune reaction
the antibodiescausesantibody mediated encephalitis
macrophages and T - lymphocytes(passive) caused byantigen - specific cell - mediated immunity
that undigested gliadin can act as antigensprovokingan antibody - mediated immune response
the MHC / TCR interactionresultsin an antibody mediated immune response
orderto causeantibodies to be made against the antigen
the general abnormalitiesleadingto antibody mediated autoimmunity
Factorsinfluencingantibody - mediated cytotoxicity
the factorsinfluenceantibody - mediated cytotoxicity
The monoclonal antibodies ... moleculescausean immune response by antibodies
b - cells and antibodiescomposehumoral immunity or antibody - mediated immunity
The monoclonal antibodies ... molecules ... ) on the surfaces of lymphoma cellscausean immune response by antibodies
dead bacteria fragments to enter the bloodstreamcausingan immune response with antibodies
by the blood proteins of the antibody and the complement(passive) caused bythe antibody - mediated immunity
where the antibiotics cause dead bacteria fragments to enter the bloodstreamcausingan immune response with antibodies
moleculescausean immune response by antibodies
molecules ... ) on the surfaces of lymphoma cellscausean immune response by antibodies
Immunizationcan influenceantibody - mediated immunity
The virus ... strong enoughto causean antibody immune response
namely , humoral responseleadingto antibody - mediated immunity
DC maturationcan leadto immunity to microbial antigen
an infection ... thosehave designedsome antibodies ( immunity
a deficiencycausesan immunodeficiency of cell - mediated immunity
articledesignedsome antibodies ( immunity
to the activation of B cells and the production of antibodiescan leadto the activation of B cells and the production of antibodies
to allergic diseaseledto allergic disease
to allergicledto allergic
to allergic and some autoimmune diseasesledto allergic and some autoimmune diseases
to chronic inflammationcould ... leadto chronic inflammation
to chronic inflammationcould ... leadto chronic inflammation
all the applied tests(passive) were influenced byall the applied tests
from TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATIONresultingfrom TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION
from TH2 CELLS activating B - LYMPHOCYTESresultingfrom TH2 CELLS activating B - LYMPHOCYTES
from TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Brucella Vaccineresultingfrom TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Brucella Vaccine
inflammation , and eventually cancercauseinflammation , and eventually cancer
from TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Radiation Toleranceresultingfrom TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Radiation Tolerance
from TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Molecular Sequence Dataresultingfrom TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Molecular Sequence Data
to the development of profound thrombocytopenia during experimental Plasmodium berghei malarialeadsto the development of profound thrombocytopenia during experimental Plasmodium berghei malaria
in the production of antibodies that are specific for and/or cross - reactresultsin the production of antibodies that are specific for and/or cross - react
from TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Mice , Transgenicresultingfrom TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Mice , Transgenic
from TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Reagent Kits , Diagnosticresultingfrom TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Reagent Kits , Diagnostic
from TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Escherichia coliresultingfrom TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Escherichia coli
from vaccinationresultsfrom vaccination
to antigen - specific escapeleadingto antigen - specific escape
from TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Plant Immunity : The inherent or induced capacity of plants to withstand or ward off biological attack by pathogensresultingfrom TH2 CELLS activating B - LYMPHOCYTES , followed by COMPLEMENT ACTIVATION.Plant Immunity : The inherent or induced capacity of plants to withstand or ward off biological attack by pathogens
to the pathology of the diseasemay ... contributeto the pathology of the disease
to T cell proliferation and differentiation into helper and effector cells with unique functionsleadingto T cell proliferation and differentiation into helper and effector cells with unique functions
to the onset and progression of neurodegenerative diseasesactively contributesto the onset and progression of neurodegenerative diseases
from the activity of antibodies in blood and lymphoid tissueresultsfrom the activity of antibodies in blood and lymphoid tissue
to vaccine - induced protection from influenza illnesscontributesto vaccine - induced protection from influenza illness
to allergic diseaseleadingto allergic disease
Disease(passive) caused byDisease
activation of complement cascadecausingactivation of complement cascade
to targetare designedto target
to the high levels of allergy and sensitivity in these patientsmay contributeto the high levels of allergy and sensitivity in these patients
to the destruction of the pathogen antibodiesleadsto the destruction of the pathogen antibodies
to extra extreme illnessleadsto extra extreme illness
to the development of profound thrombocytopenia during experimental Plasmodium berghei malarialeadsto the development of profound thrombocytopenia during experimental Plasmodium berghei malaria
vitiligocausingvitiligo
the diseasecausingthe disease
the diseaseare causingthe disease
future pandemicsto causefuture pandemics
to decreased resistanceleadingto decreased resistance
the immune system to become less sensitive to the allergen , reducing symptoms when the same allergen is encountered in the futurecausethe immune system to become less sensitive to the allergen , reducing symptoms when the same allergen is encountered in the future